IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Xortx Therapeutics Inc (XRTX)

CUSIP: 98420Q405 | NYSE | Healthcare · Biotechnology | Micro Cap | 7 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

StoneX Group Inc.15,973
0.0% of portfolio›$33.9K
Clearstead Advisors, LLC55
0.0% of portfolio›$93
TD Waterhouse Canada Inc.9
0.0% of portfolio›$15
StyleTurnoverLocationFiled
StoneX Group Inc.
15,973$33.9K0.0%ETFMediumNew York, NY2026-11-03
Clearstead Advisors, LLC
55$930.0%ETFLowCleveland, OH2026-11-06
TD Waterhouse Canada Inc.
9$150.0%CoreLowToronto, Australia2026-10-16